Variant report

Variant	esv3405350
Chromosome Location	chr4:187064783-187067331
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:171)
CpG islands
(count:733)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:171 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:187066156-187066584	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr4:187067232-187067556	H1-hESC	embryonic stem cell:	n/a	chr4:187067399-187067412
3	CTBP2	chr4:187065194-187065977	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr4:187065460-187065610	AG09309	skin:	n/a	n/a
5	CTCF	chr4:187065480-187065630	HMF	breast:	n/a	n/a
6	CTCF	chr4:187065380-187065530	SK-N-SH_RA	brain:	n/a	n/a
7	CTCF	chr4:187065380-187065530	SAEC	small airway:	n/a	n/a
8	CTCF	chr4:187066260-187066410	AG04449	skin:	n/a	n/a
9	CTCF	chr4:187065380-187065530	HCPEpiC	choroid plexus:	n/a	n/a
10	CTCF	chr4:187065380-187065530	GM12873	blood:	n/a	n/a
11	CTCF	chr4:187065480-187065630	HBMEC	blood vessel:	n/a	n/a
12	CTCF	chr4:187065420-187065570	GM12875	blood:	n/a	n/a
13	CTCF	chr4:187065400-187065550	BJ	skin:	n/a	n/a
14	CTCF	chr4:187065420-187065570	NHEK	skin:	n/a	n/a
15	CTCF	chr4:187065420-187065570	HCM	heart:	n/a	n/a
16	CTCF	chr4:187065460-187065610	AG10803	skin:	n/a	n/a
17	CTCF	chr4:187065408-187065547	Lung_OC	lung:	n/a	n/a
18	CTCF	chr4:187065340-187065490	GM12868	blood:	n/a	n/a
19	CTCF	chr4:187065449-187065498	GM19238	blood:	n/a	n/a
20	CTCF	chr4:187065380-187065530	HA-sp	spinal cord:	n/a	n/a
21	CTCF	chr4:187065440-187065590	RPTEC	kidney:	n/a	n/a
22	CTCF	chr4:187065380-187065530	HRE	kidney:	n/a	n/a
23	CTCF	chr4:187065600-187065750	HFF	foreskin:	n/a	n/a
24	CTCF	chr4:187065420-187065570	HCPEpiC	choroid plexus:	n/a	n/a
25	CTCF	chr4:187065320-187065470	GM12864	blood:	n/a	n/a
26	CTCF	chr4:187065400-187065550	HRPEpiC	eye:	n/a	n/a
27	CTCF	chr4:187065380-187065530	GM12866	blood:	n/a	n/a
28	CTCF	chr4:187065400-187065550	HUVEC	blood vessel:	n/a	n/a
29	CTCF	chr4:187065387-187065574	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr4:187065408-187065545	Fibrobl	skin:	n/a	n/a
31	CTCF	chr4:187065360-187065510	HRPEpiC	eye:	n/a	n/a
32	CTCF	chr4:187065420-187065570	HPAF	blood vessel:	n/a	n/a
33	CTCF	chr4:187065360-187065510	AoAF	blood vessel:	n/a	n/a
34	CTCF	chr4:187065440-187065590	AoAF	blood vessel:	n/a	n/a
35	CTCF	chr4:187065420-187065570	GM12864	blood:	n/a	n/a
36	CTCF	chr4:187065441-187065531	Kidney_OC	kidney:	n/a	n/a
37	CTCF	chr4:187065420-187065570	SK-N-SH_RA	brain:	n/a	n/a
38	CTCF	chr4:187065400-187065550	HMEC	breast:	n/a	n/a
39	CTCF	chr4:187065440-187065590	GM12872	blood:	n/a	n/a
40	CTCF	chr4:187065440-187065590	BE2_C	brain:	n/a	n/a
41	CTCF	chr4:187065420-187065570	AG09319	gingival:	n/a	n/a
42	CTCF	chr4:187065440-187065590	GM12874	blood:	n/a	n/a
43	CTCF	chr4:187065340-187065490	NHLF	lung:	n/a	n/a
44	CTCF	chr4:187065480-187065630	BJ	skin:	n/a	n/a
45	CTCF	chr4:187065400-187065550	Caco-2	colon:	n/a	n/a
46	CTCF	chr4:187065460-187065610	GM12867	blood:	n/a	n/a
47	CTCF	chr4:187065520-187065670	GM12869	blood:	n/a	n/a
48	CTCF	chr4:187065483-187065505	Gliobla	brain:	n/a	n/a
49	CTCF	chr4:187066242-187066350	GM19239	blood:	n/a	n/a
50	CTCF	chr4:187066260-187066410	HCPEpiC	choroid plexus:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:187065831-187065881	HCT-116	colon:	n/a
2	chr4:187065831-187065881	HCT-116	colon:	n/a
3	chr4:187065940-187065990	PrEC	prostate:	n/a
4	chr4:187065713-187065763	NHBE	bronchial:	n/a
5	chr4:187065950-187066000	Caco-2	colon:	n/a
6	chr4:187065940-187065990	ECC-1	luminal epithelium:	n/a
7	chr4:187065955-187066005	BE2_C	brain:	n/a
8	chr4:187065846-187065896	SK-N-MC	brain:	n/a
9	chr4:187065713-187065763	HUVEC	blood vessel:	n/a
10	chr4:187065944-187065994	HCPEpiC	choroid plexus:	n/a
11	chr4:187065846-187065896	CMK	blood:	n/a
12	chr4:187066279-187066329	HEK293	kidney:	embryo
13	chr4:187065417-187065467	U87	brain:	n/a
14	chr4:187065831-187065881	MCF-7	breast:	n/a
15	chr4:187065713-187065763	SAEC	small airway:	n/a
16	chr4:187066430-187066480	HCF	heart:	n/a
17	chr4:187065417-187065467	T-47D	breast:	n/a
18	chr4:187066430-187066480	AG04449	skin:	fetal
19	chr4:187066505-187066555	AG09319	gingival:	n/a
20	chr4:187065516-187065566	AG04450	lung:	fetal
21	chr4:187066430-187066480	AG04450	lung:	fetal
22	chr4:187065940-187065990	HCT-116	colon:	n/a
23	chr4:187065950-187066000	AG04449	skin:	fetal
24	chr4:187065516-187065566	CMK	blood:	n/a
25	chr4:187065940-187065990	GM12892	blood:	n/a
26	chr4:187066279-187066329	A549	lung:	n/a
27	chr4:187065713-187065763	Hepatocyte	liver:	n/a
28	chr4:187065955-187066005	NHBE	bronchial:	n/a
29	chr4:187066430-187066480	AG09319	gingival:	n/a
30	chr4:187065944-187065994	HRE	kidney:	n/a
31	chr4:187065955-187066005	GM06990	blood:	n/a
32	chr4:187065516-187065566	GM12891	blood:	n/a
33	chr4:187065846-187065896	AG09309	skin:	n/a
34	chr4:187066430-187066480	A549	lung:	n/a
35	chr4:187065516-187065566	AG09309	skin:	n/a
36	chr4:187065846-187065896	HUVEC	blood vessel:	n/a
37	chr4:187066279-187066329	GM12891	blood:	n/a
38	chr4:187066430-187066480	Hepatocyte	liver:	n/a
39	chr4:187065940-187065990	SK-N-MC	brain:	n/a
40	chr4:187065950-187066000	HNPCEpiC	eye:	n/a
41	chr4:187065955-187066005	HPAEpiC	pulmonary alveolar:	n/a
42	chr4:187065846-187065896	AoSMC	blood vessel:	n/a
43	chr4:187065417-187065467	Hepatocyte	liver:	n/a
44	chr4:187066430-187066480	NHBE	bronchial:	n/a
45	chr4:187066430-187066480	BE2_C	brain:	n/a
46	chr4:187065516-187065566	GM12892	blood:	n/a
47	chr4:187066505-187066555	H1-hESC	embryonic stem cell:	embryo
48	chr4:187065950-187066000	AG04450	lung:	fetal
49	chr4:187066505-187066555	HepG2	liver:	n/a
50	chr4:187065955-187066005	HCT-116	colon:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:187062784..187065890-chr4:187111242..187113420,3	MCF-7	breast:
2	chr4:187065362..187066941-chr4:187069127..187071220,2	K562	blood:

No data

Variant related genes	Relation type
FAM149A	TF binding region
FAM149A	CpG island
ENSG00000269302	chromatin interactions
ENSG00000109794	chromatin interactions
ENSG00000145476	chromatin interactions

Extended variants
information (count: 85 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183112399	chr4:187064830-187064831	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs560859532	chr4:187064842-187064843	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs4861703	chr4:187064873-187064874	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs540079382	chr4:187064876-187064877	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs560263184	chr4:187064895-187064896	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs528281447	chr4:187064934-187064935	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs532194579	chr4:187064939-187064940	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs552295191	chr4:187065036-187065037	Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs188880416	chr4:187065081-187065082	Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs74446092	chr4:187065144-187065145	Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs147153725	chr4:187065195-187065196	Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs568792800	chr4:187065203-187065204	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs34433394	chr4:187065231-187065232	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs368575826	chr4:187065267-187065268	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs193111159	chr4:187065302-187065303	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs371509279	chr4:187065339-187065340	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs571050872	chr4:187065346-187065347	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs115649287	chr4:187065373-187065374	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs556660138	chr4:187065417-187065418	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs138297363	chr4:187065429-187065430	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs529226280	chr4:187065454-187065455	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs372526751	chr4:187065481-187065482	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs149612033	chr4:187065512-187065513	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs184440129	chr4:187065539-187065540	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs574410354	chr4:187065541-187065542	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs549717072	chr4:187065554-187065555	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs187780256	chr4:187065579-187065580	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs376797330	chr4:187065586-187065587	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs144408866	chr4:187065614-187065615	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs532375573	chr4:187065641-187065642	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs545637136	chr4:187065690-187065691	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs562571199	chr4:187065760-187065761	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs531404503	chr4:187065836-187065837	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs367678629	chr4:187065876-187065877	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs552618305	chr4:187065877-187065878	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs548223754	chr4:187065907-187065908	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs2310392	chr4:187065924-187065925	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs527256284	chr4:187065943-187065944	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs183851187	chr4:187065974-187065975	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs571049408	chr4:187066021-187066022	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs540034141	chr4:187066066-187066067	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs6810746	chr4:187066139-187066140	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs2310391	chr4:187066140-187066141	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs907438	chr4:187066198-187066199	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs373978546	chr4:187066228-187066229	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs555427925	chr4:187066238-187066239	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs111473416	chr4:187066266-187066267	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs116132263	chr4:187066279-187066280	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs573162723	chr4:187066293-187066294	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs554041603	chr4:187066369-187066370	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
abnormal development	18461090	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16774939	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	17053054	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Facioscapulohumeral muscular dystrophy	21829175	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17086460	CNVD
Autism	18414403	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:479 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:187039200-187065000	Weak transcription	Fetal Brain Female	brain
2	chr4:187050600-187065000	Weak transcription	Gastric	stomach
3	chr4:187054200-187065000	Weak transcription	Fetal Kidney	kidney
4	chr4:187054400-187065000	Weak transcription	Fetal Intestine Small	intestine
5	chr4:187055000-187065000	Weak transcription	Fetal Intestine Large	intestine
6	chr4:187058600-187065200	Weak transcription	Pancreas	Pancrea
7	chr4:187058800-187064800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr4:187058800-187064800	Weak transcription	Stomach Smooth Muscle	stomach
9	chr4:187058800-187065000	Weak transcription	Adipose Nuclei	Adipose
10	chr4:187058800-187065000	Weak transcription	Liver	Liver
11	chr4:187058800-187065200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr4:187058800-187065200	Weak transcription	Rectal Mucosa Donor 31	rectum
13	chr4:187060200-187065200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr4:187061600-187065000	Weak transcription	NHDF-Ad	bronchial
15	chr4:187063600-187064800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr4:187063600-187065000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr4:187063600-187065000	Weak transcription	Rectal Mucosa Donor 29	rectum
18	chr4:187064000-187065200	Weak transcription	Fetal Stomach	stomach
19	chr4:187064400-187065200	Enhancers	Fetal Brain Male	brain
20	chr4:187064800-187065000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr4:187064800-187065000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr4:187064800-187065000	Enhancers	Stomach Smooth Muscle	stomach
23	chr4:187064800-187065000	Enhancers	NH-A	brain
24	chr4:187064800-187065200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr4:187065000-187065200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
26	chr4:187065000-187065200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr4:187065000-187065200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
28	chr4:187065000-187065200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr4:187065000-187065200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
30	chr4:187065000-187065200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
31	chr4:187065000-187065200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr4:187065000-187065200	Active TSS	Breast Myoepithelial Primary Cells	Breast
33	chr4:187065000-187065200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr4:187065000-187065200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr4:187065000-187065200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr4:187065000-187065200	Enhancers	Cortex derived primary cultured neurospheres	brain
37	chr4:187065000-187065200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr4:187065000-187065200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr4:187065000-187065200	Active TSS	Brain Anterior Caudate	brain
40	chr4:187065000-187065200	Flanking Active TSS	Brain Cingulate Gyrus	brain
41	chr4:187065000-187065200	Active TSS	Brain Inferior Temporal Lobe	brain
42	chr4:187065000-187065200	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
43	chr4:187065000-187065200	Enhancers	Colonic Mucosa	Colon
44	chr4:187065000-187065200	Flanking Active TSS	Colon Smooth Muscle	Colon
45	chr4:187065000-187065200	Enhancers	Duodenum Mucosa	Duodenum
46	chr4:187065000-187065200	Active TSS	Duodenum Smooth Muscle	Duodenum
47	chr4:187065000-187065200	Enhancers	Fetal Brain Female	brain
48	chr4:187065000-187065200	Enhancers	Fetal Heart	heart
49	chr4:187065000-187065200	Enhancers	Fetal Intestine Large	intestine
50	chr4:187065000-187065200	Enhancers	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links